AstraZeneca PLC
American Depositary Receipt · NASDAQ
Live TMS charts are coming soon.
Paper trading. Simulated, no real money.
No public theses on AZN yet. When TMS traders open paper trades on it and make their thesis public, the long and short split, average conviction and hit rate show here.
Key stats load once market data is connected.
AstraZeneca reportedly received FDA priority review for a gastric cancer therapy, which could speed up the agency's decision timeline. The headline is the only detail available, so the regulatory outcome is still pending.
AstraZeneca has received FDA priority review for a gastric cancer therapy, a step that typically shortens the agency's review timeline. The headline is the only detail available, so the broader impact on the company's pipeline is not yet clear.
No SEC financials for AZN yet. Companies that file 10-K and 10-Q reports show revenue, earnings, cash flow and the balance sheet here.
Source: SEC filings (10-K, 10-Q).
Paper trading only. Nothing here is financial advice.